Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure

Recruiting

• Conditions: Emergencies; Acute Heart Failure

• Registration Number: NCT05871138
• Lead Sponsor: University of Monastir

Brief Summary

prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.

Detailed Description

The aim of our study is to evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac decompensation 30 days after discharge.

Delta LUS score=((LUS2-LUS1) \*100)/LUS1

Study Timeline

• Study First Submitted: 2023-03-17
• Study Start: 2023-03-30
• Status Verified: 2023-05
• Study First Submitted QC: 2023-05-13
• Last Update Submitted: 2023-05-13
• Study First Posted: 2023-05-23
• Last Update Posted: 2023-05-23
• Primary Completion: 2023-12-30
• Study Completion: 2023-12-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients aged over 18 years,
• Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).

Exclusion Criteria

• Age less than 18 years
• Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...)
• Altered state of consciousness (Glasgow score<14)
• Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs
• Mechanical ventilation from the outset
• Cardiorespiratory arrest
• Inability to give consent to the study
• Missing one of two ultrasound examinations
• Unable to make telephone contact after one month.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Readmission	30 days	Readmission
Delta lus	30 days	The primary outcome evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac

Trial Locations

Locations (2)

Semir Nouira; 🇹🇳 Monastir, Monastur, Tunisia

Emergency Departement; 🇹🇳 Monastir, Tunisia